Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 27, 2024
Corrigendum to "Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia" [Nanomed: Nanotechnol Biol Med 29C (2020) 102236]
Vijaya Pooja Vaikari, Mincheol Park, Lena Keossayan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 15, 2020
Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia
Vijaya Pooja Vaikari, Mincheol Park, Lena Keossayan, et al.
Bioconjugate Chemistry
|
April 23, 2020
Human Granulocyte-Macrophage Colony-Stimulating Factor Fused to Elastin-Like Polypeptides Assembles Biologically-Active Nanoparticles
Mincheol Park, Vijaya P Vaikari, Jugal P Dhandhukia, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 5, 2022
Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia
Sharon Wu, Mengxi Wang, Amani Alqahtani, et al.
Science Translational Medicine
|
October 24, 2014
TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis
Yo Matsuo, Jae-Hyun Park, Takashi Miyamoto, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 20, 2020
Anti-FLT3 nanoparticles for acute myeloid leukemia: Preclinical pharmacology and pharmacokinetics
Mincheol Park, Vijaya Pooja Vaikari, Albert T Lam, et al.
Blood Cancer Discovery
|
September 18, 2020
Apolipoprotein C2 - CD36 Promotes Leukemia Growth and Presents a Targetable Axis in Acute Myeloid Leukemia
Tian Zhang, Jiawen Yang, Vijaya P Vaikari, et al.
Pharmacology & Therapeutics
|
April 3, 2021
Strategies targeting FLT3 beyond the kinase inhibitors
Mohammed F Almatani, Atham Ali, Sandra Onyemaechi, et al.
Frontiers in Immunology
|
December 1, 2022
pyTCR: A comprehensive and scalable solution for TCR-Seq data analysis to facilitate reproducibility and rigor of immunogenomics research
Kerui Peng, Jaden Moore, Mohammad Vahed, et al.
Journal of Clinical Immunology
|
May 5, 2021
Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia
Che-Mai Chang, Po-Hao Feng, Tsung-Hsun Wu, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 27, 2024
Corrigendum to "Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia" [Nanomed: Nanotechnol Biol Med 29C (2020) 102236]
Vijaya Pooja Vaikari, Mincheol Park, Lena Keossayan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 15, 2020
Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia
Vijaya Pooja Vaikari, Mincheol Park, Lena Keossayan, et al.
Bioconjugate Chemistry
|
April 23, 2020
Human Granulocyte-Macrophage Colony-Stimulating Factor Fused to Elastin-Like Polypeptides Assembles Biologically-Active Nanoparticles
Mincheol Park, Vijaya P Vaikari, Jugal P Dhandhukia, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 5, 2022
Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia
Sharon Wu, Mengxi Wang, Amani Alqahtani, et al.
Science Translational Medicine
|
October 24, 2014
TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis
Yo Matsuo, Jae-Hyun Park, Takashi Miyamoto, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 20, 2020
Anti-FLT3 nanoparticles for acute myeloid leukemia: Preclinical pharmacology and pharmacokinetics
Mincheol Park, Vijaya Pooja Vaikari, Albert T Lam, et al.
Blood Cancer Discovery
|
September 18, 2020
Apolipoprotein C2 - CD36 Promotes Leukemia Growth and Presents a Targetable Axis in Acute Myeloid Leukemia
Tian Zhang, Jiawen Yang, Vijaya P Vaikari, et al.
Pharmacology & Therapeutics
|
April 3, 2021
Strategies targeting FLT3 beyond the kinase inhibitors
Mohammed F Almatani, Atham Ali, Sandra Onyemaechi, et al.
Frontiers in Immunology
|
December 1, 2022
pyTCR: A comprehensive and scalable solution for TCR-Seq data analysis to facilitate reproducibility and rigor of immunogenomics research
Kerui Peng, Jaden Moore, Mohammad Vahed, et al.
Journal of Clinical Immunology
|
May 5, 2021
Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia
Che-Mai Chang, Po-Hao Feng, Tsung-Hsun Wu, et al.
Page
of 6